Status:

COMPLETED

Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients

Lead Sponsor:

Saglik Bilimleri Universitesi

Conditions:

Acceptance and Commitment Therapy

Psychotic Disorders

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study is to examine the effect of Acceptance and Commitment Therapy applied to patients in early psychosis patients on psychotic symptoms and functionality levels.

Detailed Description

This study is a pretest, posttest, follow-up, randomized controlled experimental study. This study will be conducted at the Health Sciences University Sultan II. Abdulhamid Han Training and Research H...

Eligibility Criteria

Inclusion

  • The consent of himself/herself or his/she guardian to participate in the research,
  • Being diagnosed with schizophrenia and other psychotic disorders for a minimum of six months and a maximum of three years according to DSM-V diagnostic criteria,
  • Not to be in the acute attack period of the disease,
  • The home environment is suitable for online conversation (computer/smartphone, internet at home, the patient can be alone in the room during the session, etc.)
  • Being between the ages of 18-65,
  • Ability to read and write,
  • There is no communication problem at a level that prevents the conversation,
  • Absence of mental retardation, neurocognitive disorder, alcohol and substance abuse

Exclusion

  • Her/his is or her/his is guardian's refusal to participate in the research,
  • Being diagnosed with schizophrenia and other psychotic disorders for less than six months or for more than three years, according to DSM-V diagnostic criteria,
  • Being in the acute attack period of the disease,
  • Not being able to read and write,
  • Having a communication problem at a level that prevents the conversation,
  • Having mental retardation, neurocognitive disorder, alcohol and substance addiction

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2022

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05210816

Start Date

January 1 2022

End Date

September 30 2022

Last Update

June 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Saglik Bilimleri Universitesi

Istanbul, Turkey (Türkiye), 34668